Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
79,928.290000 Euro
Request Reference:
590080/24
Request Name:
Aquisição de medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
Phase:
Tendering Phase
State:
Awarded
Description:
Aquisição de medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
C894 - CINACALCET [30 MG; CÁP/COMP]
-
365
(
Days
)
C895 - CINACALCET [60 MG; CÁP/COMP]
-
365
(
Days
)
H88 - HIDROCORTISONA [100MG; F/AMP]
-
365
(
Days
)
P5 - PAMIDRONATO de SÓDIO [90MG; F/AMP]
-
365
(
Days
)
D39 - DEXAMETASONA [5MG/1ML; F/AMP]
-
365
(
Days
)
D363 - DEXAMETASONA [8 MG; COMP]
-
365
(
Days
)
D83 - DICLOFENAC [75MG; IM; F/AMP]
-
365
(
Days
)
G88 - GLUCAGOM [1MG; F/SER]
-
365
(
Days
)
I3 - IBUPROFENO 2% [20 MG/ ML; SUSP ORAL; FRS]
-
365
(
Days
)
I221 - INSULINA HUMANA (acção cutra) [100 UI/ML; CARTUCHO]
-
365
(
Days
)
M109 - METILPREDNISOLONA (succinato) [40MG; IM/ IV; F/AMP]
-
365
(
Days
)
M105 - METILPREDNISOLONA [125MG; F/AMP]
-
365
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Largo Senhor da Pobreza PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
4/26/2024 11:11 AM
(UTC +1 hour)
National official publishing date and time (DR):
2/22/2021 9:50 AM
(UTC 0 hours)
Due datetime for receiving replies:
5/3/2024 6:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Procuração Vortal 2024.pdf
Procuração Vortal 2024.pdf
Download
Peças procedimentais_aquisição de medicamentos do aparelho locomotor_590080.24_Vortal.pdf
Peças procedimentais_aquisição de medicamentos do aparelho locomotor_590080.24_Vortal.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
C894 - CINACALCET [30 MG; CÁP/COMP]
Base Price
37 200,000000
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
C894
CINACALCET [30 MG; CÁP/COMP]
12 000,000000
UN
Buyer Comment:
502248793 | Mylan, Lda. | CPA:2021047/120/0172 | NºAIM:5688601; 502942959 | Amgen Biofarmacêutica, Lda. | CPA:2021047/103/0336 | NºAIM:5239785; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2021047/334/0046 | NºAIM:5674528; 508107997 | Generis Farmacêutica, S.A. | CPA:2021047/263/0095 | NºAIM:5773627; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2021047/528/0293 | NºAIM:5795257;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
C895 - CINACALCET [60 MG; CÁP/COMP]
Base Price
20 832,000000
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
C895
CINACALCET [60 MG; CÁP/COMP]
3 360,000000
UN
Buyer Comment:
502248793 | Mylan, Lda. | CPA:2021047/120/0173 | NºAIM:5688627; 502942959 | Amgen Biofarmacêutica, Lda. | CPA:2021047/103/0337 | NºAIM:5240189; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2021047/334/0047 | NºAIM:5674544; 508107997 | Generis Farmacêutica, S.A. | CPA:2021047/263/0096 | NºAIM:5773619; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2021047/528/0294 | NºAIM:5795265;
TOTAL
(The amounts shown do not include VAT)
3
Lot Title
H88 - HIDROCORTISONA [100MG; F/AMP]
Base Price
16 745,600000
3.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
H88
HIDROCORTISONA [100MG; F/AMP]
16 000,000000
UN
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2021047/96/0194 | NºAIM:3285582; 502595442 | Pharmis Biofarmacêutica, Lda. | CPA:2021047/82/0187 | NºAIM:5752803; 508107997 | Generis Farmacêutica, S.A. | CPA:2021047/263/0115 | NºAIM:5801634;
TOTAL
(The amounts shown do not include VAT)
4
Lot Title
P5 - PAMIDRONATO de SÓDIO [90MG; F/AMP]
Base Price
393,600000
4.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
P5
PAMIDRONATO de SÓDIO [90MG; F/AMP]
20,000000
UN
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2021047/96/0192 | NºAIM:3967783; 503894427 | D.L.A. Farmaceutica, S.A. | CPA:2021047/542/0256 | NºAIM:5663091;
TOTAL
(The amounts shown do not include VAT)
5
Lot Title
D39 - DEXAMETASONA [5MG/1ML; F/AMP]
Base Price
900,000000
5.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
D39
DEXAMETASONA [5MG/1ML; F/AMP]
750,000000
UN
Buyer Comment:
513077332 | BDR Pharma, Lda. | CPA:2021047/896/0319 | NºAIM:3974581;
TOTAL
(The amounts shown do not include VAT)
6
Lot Title
D363 - DEXAMETASONA [8 MG; COMP]
Base Price
112,000000
6.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
D363
DEXAMETASONA [8 MG; COMP]
800,000000
UN
Buyer Comment:
507981227 | Krka Farmacêutica, Lda. | CPA:2021047/901/0054 | NºAIM:5691670;
TOTAL
(The amounts shown do not include VAT)
7
Lot Title
D83 - DICLOFENAC [75MG; IM; F/AMP]
Base Price
1 360,000000
7.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
D83
DICLOFENAC [75MG; IM; F/AMP]
8 500,000000
UN
Buyer Comment:
501169580 | Labesfal - Laboratórios Almiro, S.A. | CPA:2021047/107/0213 | NºAIM:5554274;
TOTAL
(The amounts shown do not include VAT)
8
Lot Title
G88 - GLUCAGOM [1MG; F/SER]
Base Price
341,250000
8.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
G88
GLUCAGOM [1MG; F/SER]
25,000000
UN
Buyer Comment:
501485210 | Novo Nordisk Portugal, Lda. | CPA:2021047/129/0216 | NºAIM:2150084;
TOTAL
(The amounts shown do not include VAT)
9
Lot Title
I3 - IBUPROFENO 2% [20 MG/ ML; SUSP ORAL; FRS]
Base Price
62,500000
9.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
I3
IBUPROFENO 2% [20 MG/ ML; SUSP ORAL; FRS]
50,000000
UN
Buyer Comment:
501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2021047/46/0276 | NºAIM:5684873; 508107997 | Generis Farmacêutica, S.A. | CPA:2021047/263/0116 | NºAIM:5223383;
TOTAL
(The amounts shown do not include VAT)
10
Lot Title
I221 - INSULINA HUMANA (acção cutra) [100 UI/ML; CARTUCHO]
Base Price
177,840000
10.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
I221
INSULINA HUMANA (acção cutra) [100 UI/ML; CARTUCHO]
60,000000
UN
Buyer Comment:
500165602 | Lilly Portugal - Produtos Farmacêuticos, Lda. | CPA:2021047/112/0140 | NºAIM:2295780; 501485210 | Novo Nordisk Portugal, Lda. | CPA:2021047/129/0224 | NºAIM:4130084;
TOTAL
(The amounts shown do not include VAT)
11
Lot Title
M109 - METILPREDNISOLONA (succinato) [40MG; IM/ IV; F/AMP]
Base Price
250,000000
11.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
M109
METILPREDNISOLONA (succinato) [40MG; IM/ IV; F/AMP]
250,000000
UN
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2021047/96/0203 | NºAIM:8303800; 502266791 | Hikma Farmacêutica, S.A. | CPA:2021047/62/0378 | NºAIM:5599949;
TOTAL
(The amounts shown do not include VAT)
12
Lot Title
M105 - METILPREDNISOLONA [125MG; F/AMP]
Base Price
1 553,500000
12.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
M105
METILPREDNISOLONA [125MG; F/AMP]
650,000000
UN
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2021047/96/0195 | NºAIM:8303818; 502266791 | Hikma Farmacêutica, S.A. | CPA:2021047/62/0024 | NºAIM:5599964;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - C894 - CINACALCET [30 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Definir normas de desempate?
Sim
Não
2 - C895 - CINACALCET [60 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
3 - H88 - HIDROCORTISONA [100MG; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
4 - P5 - PAMIDRONATO de SÓDIO [90MG; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
5 - D39 - DEXAMETASONA [5MG/1ML; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
6 - D363 - DEXAMETASONA [8 MG; COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
7 - D83 - DICLOFENAC [75MG; IM; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
8 - G88 - GLUCAGOM [1MG; F/SER]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
9 - I3 - IBUPROFENO 2% [20 MG/ ML; SUSP ORAL; FRS]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
10 - I221 - INSULINA HUMANA (acção cutra) [100 UI/ML; CARTUCHO]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
11 - M109 - METILPREDNISOLONA (succinato) [40MG; IM/ IV; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
12 - M105 - METILPREDNISOLONA [125MG; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...